The Innovation Center supports new and innovative companies that are focused on Healthcare Technologies and Medical Devices.
To date we are home to nine start-ups in the Southwest Riverside County area & house several resource organizations.
Murrieta Genomics is dedicated to finding those answers and advancing the use of genomic sequencing in precision medicine, agriculture, forensics, veterinary and direct to consumer applications by offering entrepreneurs access to the specialized equipment, know-how and mentors that can transform research into commercial enterprise.
SimplSeq has developed a proprietary process to prepare biological samples for next generation genomic sequencing processing that will save thousands of labs a great deal of time and expense. While the time and cost of the sequencing of DNA and RNA has dropped substantially, the process of extracting DNA or RNA from a biological sample, purifying it, and making enough copies to get a good read has basically remained the same.
GattaCo Inc. is a young Southern California startup company that develops solutions for the life science and medical industry.
GattaCo’s mission is to enable next generation diagnostics and simplified sample collection and processing. We do this by leveraging our patented Capillary Pressure Re-Set (or Cap-Reset™) Technology to create novel products and solutions for our partners.
Neyroblast GX's focus is to develop next-generation theranostic products for neurodegenerative and infectious diseases like Alzheimer’s disease and COVID-19. We also have a platform to provide custom-made human organoids and genetically engineered cells for screening drug, toxicity, and disease pathology. Our team of scientists comes from a range of backgrounds across academia, biotech, and pharma with extensive experience in nutraceutical biomedicine, genetics, neurobiology, drug development, and human stem cells.
Swellter is a patient immersion platform that is enriching the oncology patient-provider experience through consent, education, and data sharing in real-time. Swellter opens a window through which laboratory and pharmaceutical companies can share relevant and potentially transformative diagnostic and therapeutic options with oncologists and cancer patients. We are steadfast in building a transformative platform that will change the patient experience and engage all oncology stakeholders.
TRIO Pharmaceuticals, Inc. is a cancer immunotherapeutics company pioneering dual action drugs to generate immunogenic tumors. TRIO's innovative antibody drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. TRIO is developing a proprietary platform of dual action tumor immunity-enhancing drugs aimed at treating cancers of high unmet medical needs by targeting specific antigens on the cancer cells and immunosuppressor cells in the tumor microenvironment. TRIO has an experienced team that has developed FDA-approved drugs.
Under the agreement, the newly formed EPIC SBDC Resource Center will build on MIC’s current programming and business mentoring by leveraging the expertise of the EPIC SBDC’s pool of 15 entrepreneurs-in-residence (EIR) to provide hands-on consulting to tech-focused and scalable startups.
More Information Coming
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.